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ABSTRACT  
 
Although prior research has identified negative consequences from marijuana use, 
some states are legalizing marijuana for medical use due to its medical utility. In 2010, 
the State of Arizona passed medical marijuana legislation, yet, to date, little research has 
been published about the specific population characteristics of medical marijuana users or 
their criminal activity. The purpose of this study is to present the characteristics of 
medical marijuana users and examine the relationship between medical marijuana use 
and crime, including substance use, by comparing four groups which are medical 
marijuana users with authorized medical marijuana ID card (authorized medical 
marijuana users, AuMM users), medical marijuana users without authorized medical 
marijuana ID card (non-authorized medical marijuana users, NonAuMM users), illegal 
marijuana users without authorized medical marijuana ID card (non-authorized marijuana 
users, NonAuM users), and non-marijuana users (Non-users). Data were collected from a 
sample of recently booked arrestees in Maricopa County, Arizona through the Arizona 
Arrestee Reporting Information Network (AARIN) project. A total of 2,656 adult 
arrestees participated in the study. Findings show that authorized medical marijuana users 
were more likely to be male, younger, and high school graduates. Medical marijuana 
users, on average, were likely to acquire more marijuana and spend more money on 
obtaining marijuana compared to non-authorized marijuana users. Whereas the 
authorized medical marijuana users had a higher probability for DUI and drug 
selling/making than non-marijuana users, non-authorized medical marijuana users had a 
higher probability for involvement property crime, violent crime, DUI, and drug 
ii 
 
selling/making than non-marijuana users. Authorized medical marijuana users were less 
likely to use meth compared to non-authorized medical marijuana users and non-
authorized marijuana users. This study suggests that it is important to recognize the non-
authorized medical marijuana users under medical marijuana policy as well as the DUI 
regulations and medical insurance.    
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CHAPTER 1 
INTRODUCTION 
Marijuana, also known as cannabis, has an approximately 5000-year history of 
medical use throughout the world (Pertwee, 2006) and has been used as a traditional 
medical remedy in Asian countries, Africa, ancient Greece, and medieval Europe (Cohen, 
2009). Recently, however, the debate on medical marijuana has been passionately 
presented in the United States. Marijuana is the most frequently used illicit substance, 
and marijuana abuse and dependence are highly prevalent in the United States (American 
Psychiatric Association, 2000; Johnston, O’Malley, Bachman, & Schulenbery, 2010). In 
1970, the United States Congress created a series of five schedules establishing varying 
degrees of control over  substances under the federal Controlled Substances Act (Kampia 
& Thomas, 1996). Marijuana is classified as a Schedule I drug, which means that (1) it 
has a high potential for abuse, (2) it has no currently accepted medical use in treatment in 
the United States, and (3) there is a lack of accepted safety for its use under medical 
supervision (Gerber, 2004). In addition, chronic and/or regular use of marijuana is 
associated with the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 
diagnoses of marijuana use disorders (Grant & Pickering, 1998). Such disorders are 
associated with negative consequences, such as unemployment, personality dysfunction, 
crime, respiratory problems, and other psychiatric disorders (Budney & Moore, 2002; 
Hall & Lynskey, 2009; Hasin, Keyes, Alderson, Wang, Aharonovich, & Grant, 2008; 
Pedersen & Skardhamar, 2010; Taylor, Poulton, Moffitt, Ramankutty, & Sears, 2000). A 
recent meta-analysis pointed to an association between marijuana use and criminal 
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involvement, although the marijuana and crime association was not as strong as the 
relationship between crime and other illegal substances, such as amphetamines, cocaine, 
and opiates (Bennett, Holloway, & Farrington, 2008). 
Some researchers emphasize its medical benefit and argue that marijuana is safe 
and efficacious for treating serious illnesses (Abrams, Jay, Shade, Vizoso, Reda, Press, 
Kelly, Rowbotham, & Petersen, 2007; Corey-Bloom, Wolfson, Gamst, Marcotte, Bentley, 
& Gouaus, 2012; Ware, Wang, Shapiro, Robinson, Ducruet, Huynh, Gamsa, Bennett, & 
Collet, 2010). Clinical research shows that marijuana reduces chronic pain, nausea, 
vomiting, muscle spasms, and loss of appetite (Eddy, 2010; Marmor, 1998; Martinz, 
2000; Watson, Benson, & Joy, 2000). Marijuana can be used to treat the side effects of 
chemotherapy, as well as the symptoms of Acquired Immunodeficiency Syndrome 
(AIDS), multiple sclerosis, epilepsy, glaucoma, and other serious illnesses (Martinz, 
2000). People also argue that there is no documented evidence of non of death resulting 
from marijuana use, even in large doses, and it is less addictive than other legal drugs, 
such as alcohol or nicotine (Rosenthal & Kubby, 2003). Recently, several studies have 
found that marijuana can be used to treat other substance abuse/dependence (e.g., alcohol, 
prescription drugs, or opiates) as it is perceived to be a safer option than the substances 
on which  individuals were formerly dependent (Cohen, 2009; Reiman, 2009).  
Given the medical utility of marijuana, many states have started to consider 
medical marijuana legalization. In April 2014, Maryland became the 21st state, along 
with the District of Columbia, to enact a medical marijuana law (ProCon.org, 2014). 
More states, including New York and Pennsylvania, have recently considered medical 
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marijuana legalization (Anderson, Hansen, & Rees, 2013); and Washington and Colorado 
recently legalized recreational marijuana. In 2010, the State of Arizona passed medical 
marijuana legislation, and the Arizona Department of Health Services (ADHS) began to 
provide identification cards for qualifying patients, in addition to allocating dispensary 
registration certificates. The number of qualifying patients and legal marijuana 
dispensaries has expanded rapidly.  
Despite the increasing support for medical marijuana, controversial issues related 
to legalizing medical marijuana use still exist in terms of social contexts, especially in 
terms of the crime. Opponents of medical marijuana legalization argue that legalizing 
medical marijuana will lead to increase a crime. For example, some people who have 
medical marijuana ID cards can acquire marijuana for non-medical purposes and abuse it. 
Medical marijuana dispensaries can also be one of the supply sources for recreational use 
or other criminal activities (e.g., theft, burglary, or robbery at dispensaries). This 
possibility can lead to an illegal marijuana trade between medical marijuana ID card 
holders and people who want to access marijuana more easily. Physical fights can occur 
during such transactions. Vickovic (2011) examined articles describing medical 
marijuana-related crimes and found that 61.5% (8 of 13) them of focused on either a 
robbery or murder. He also found that several of these articles described criminal 
victimization among medical marijuana users because they possessed medical marijuana 
plants.  
Meanwhile, proponents of medical marijuana legalization argue that legalizing 
medical marijuana can control marijuana-related crime. For example, the legalization of 
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medical marijuana allows people to obtain marijuana in legitimate ways and avoid 
involvement in dangerous, illicit marijuana marketplaces (O’Brien, 2013). It will also 
help individuals who might not have connections to the illegitimate economy (e.g., illegal 
drug dealers) to attain economic legitimacy (O’Brien, 2013) as people can work at a 
regulated dispensary system. 
However, little is known about the characteristics of those who use medical 
marijuana, including those who illegally use medical marijuana, and there is little 
published research about the relationship between medical marijuana use and criminal 
involvement. The purpose of this study is to examine the characteristics of medical 
marijuana users who were arrested in Maricopa County, AZ and to examine the 
relationship between the types of marijuana use and criminal involvement.  
As more states are considering medical marijuana legalization, this study will 
provide a practical explanation of particular social perspectives that need to be considered 
in the dialogue over legalizing medical marijuana. Chapter 2 will present the literature 
review, which includes an introduction of medical marijuana, a modern history of 
medical marijuana legalization in the United States, and a discussion indicating the 
characteristics of marijuana users in prior empirical research. The crime-related literature 
will also be discussed. Chapter 3 describes the study methodology including a description 
of the data collection process, sample, the process for coding variables, and the analytic 
strategy. In Chapter 4, the results of bivariate and multivariate analyses are presented. 
Finally, the findings and policy implications of the study are discussed, as well as the 
limitations of this study and suggestions for future research in Chapter 5.  
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CHAPTER 2 
LITERATURE REVIEW 
Medical Marijuana (Cannabis) 
According to the National Institute on Drug Abuse (NIDA, 2012), “medical-grade” 
marijuana sold in legitimate dispensaries is the same quality and carries the same health 
effects as “street” marijuana, which is generally recognized as a narcotic drug with high 
potential for abuse. Although medical marijuana and street marijuana are physically the 
same substance, they can affect people differently, based on their usage patterns and 
motivations for marijuana use. It is important to understand the fundamental function of 
marijuana in the human body based on scientific evidence in order to assess its safe and 
efficacious uses.  
Marijuana is a product of the Cannabis Sativa plant and contains more than 400 
other chemical compounds that can be biologically active (NIDA, 2012). The main active 
ingredient of cannabis is delta-9-tetrahydrocannabinol (THC); marijuana usually contains 
10% to 25% THC. When THC is ingested by the human body, it mimics 
endocannabinoids which are naturally produced in the body and play an important role in 
normal brain development and function. The insights about endocannabinoids have 
begun helping researchers design treatments to deploy the medicinal properties of the 
marijuana plant. Endocannabinoids activate specific molecular targets on brain cells, 
called cannabinoid receptors that influence pleasure, memory, thinking, concentration, 
sensory, and coordinated movement (NIDA, 2012). A marijuana overdose can lead to the 
over-activation of the endocannabinoid system, which can cause negative brain 
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functioning, including distorted perception, difficulty thinking, and disrupted learning 
and memory (NIDA, 2012).  
Cannabinoid drugs, under the appropriate medical supervision, may offer a 
broader spectrum relief than any other single medication (Jackson, 2013).  The 
cannabinoid receptors in the brain stem and spinal cord play a role in pain control; 
clinical research has demonstrated the analgesic efficacy of cannabis (Abrams et al., 2007; 
Ellis, Toperoff, Vaida, Brande, Gonzales, Gouaus, Bently, & Atkinson, 2009; Wilsey, 
Marcotte, Tsodikov, Millman, Bently, Gouaus, & Fishman, 2008).  Abrams et al. (2007) 
conducted experimental research with a randomized placebo-controlled trial to examine 
the effect of smoked marijuana on the neuropathic pain of HIV-associated sensory 
neuropathy. The study found that participants who smoked marijuana felt more reduced 
daily pain than participants in the placebo group. Over a 5-day inpatient intervention 
period, greater than 30% reduction in pain was reported by 52% in the cannabis group 
and by 24% in the placebo group. No serious adverse effects were reported. In addition, 
Wilsey et al. (2008) found that cannabis reduced pain unpleasantness, as well as its 
intensity, among the participants with complex regional pain syndrome (CRPS type I), 
spinal cord injury, peripheral neuropathy, or nerve injury.       
The cannabinoid receptors also play a role in controlling the vomiting reflex, 
appetite, and emotional responses. Meiri, Jhangiani, Vredenburgh, Barbato, Carter, Yang 
and Baranowski (2007) conducted a placebo-controlled study and found that the synthetic 
form of THC (Dronabinol) reduced nausea and vomiting among patients who were 
receiving chemotherapy; the absence of nausea and vomiting/retching were significantly 
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greater in patients treated with dronabinol (54%) than patients in the placebo group 
(20%). Walsh, Kirkova, and Davis (2005) conducted a study to research the effects of 
dronabinol on anorexia among cancer patients and found that dronabinol improved 
appetite in almost 50% of patients. A recent study conducted by Greer, Grob, and 
Halberstadt (2014) evaluated the effects of cannabis on PTSD symptoms among patients 
who were in the New Mexico Department of Health’s Medical Cannabis Program for 
PTSD. The authors found that patients reported a greater than 75% reduction in the 
Clinician Administered Posttraumatic (CAPS) Scale for DSM-IV symptom scores when 
they were using cannabis compared to when they were not.  
Given these medicinal properties, cannabis has been used to treat the debilitating 
symptoms of cancer and cancer chemotherapy, AIDS, multiple sclerosis, epilepsy, 
glaucoma, and anxiety. In the United States, there are three FDA-approved 
pharmaceutical drugs based on cannabis: Sativex, Dronabinol (Marinol), and Nabilone 
(Cesamet) (Pisanti, Malfitano, Grimaldi, Santoro, Gazzerro, Laezza, & Bifulco, 2009). 
Sativex, which is a combination of THC and cannabidiol (CBD), is derived from natural 
extracts of the cannabis plant. It is approved in several countries, including the UK, Spain, 
Canada, Denmark, Germany, Sweden, Austria, Italy, and Switzerland, as adjunctive 
treatment for the symptomatic relief of neuropathic pain in multiple sclerosis and in 
cancer. Dronabinol, a synthetic form of THC and Cesamet, a synthetic THC analogue, 
are currently used for chemotherapy-induced nausea and vomiting in patients who have 
failed to respond adequately to conventional anti-emetic compounds. Dronabinol is also 
approved for the treatment of anorexia associated with AIDS. Although empirical 
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research revealed the effectiveness of cannabis on chronic illnesses, medical marijuana 
use has been an ongoing issue, and regulation of marijuana have been debated in the 
United States for decades.  
Modern History of Medical Marijuana Legalization in the United States 
From 1850 to 1941, marijuana was listed in the United States Pharmacopeia and 
National Formulary (NF) and was used for medical purposes in the United States 
(Gianutsos, 2010). However, in 1937, the Marijuana Tax Act—the first federal regulation 
directly concerned with marijuana—was passed after research indicated a link between 
marijuana smoking and deviant behaviors; this act prohibited marijuana use for 
recreational purposes (Aderson, Hansen, & Rees, 2013). Yet medical use of marijuana 
remained acceptable, with permission from physicians and pharmacists, who could 
prescribe or dispense marijuana after registering and paying a substantial tax (Gianutsos, 
2010). Following the Marijuana Tax Act, more laws were established to control 
marijuana use by imposing harsher penalties, including the Boggs Act (1951) and the 
Narcotic Control Act (1956). In 1970, Congress enacted the Comprehensive Drug Abuse 
Prevention and Control Act, also referred to as the Controlled Substances Act, which 
categorized marijuana as a Schedule I controlled substance. Under this act, marijuana 
could no longer be prescribed legally by physicians or pharmacists. However, some 
individuals subsequently recommended the decriminalization of marijuana due to its 
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unique medical benefits. As a result, many legal battles related to medical marijuana have 
taken place.
1
  
In 1985, the Food and Drug Administration (FDA) approved a pill form of a 
synthetic version of THC, the medically beneficial component of marijuana, for use in 
treating vomiting, nausea, and rapid weight loss in AIDS patients. Many patients 
complained about problems with the synthetic THC (e.g., difficulty in taking the pill 
orally) and reported significantly better effects in controlling pain and nausea from 
natural marijuana. Indeed, some of them preferred to use marijuana illegally (Bergstrom, 
1997).  In 1972, the first petition was filed with the Bureau of Narcotics and Dangerous 
Drugs (BNDD, now the U.S. Drug Enforcement Administration (DEA) to reschedule 
marijuana. This petition called for the removal of marijuana from the Controlled 
Substance Act or reclassification of it as a Schedule V drug—the least restrictive 
category. However, the petition was rejected. In 1994, the call for marijuana rescheduling 
from Schedule I to Schedule II was also denied in Alliance for Cannabis Therapeutics v. 
Drug Enforcement Administration. Despite such efforts, marijuana remains a Schedule I 
drug (Bergstrom, 1997). 
Yet since 1996, some states have legalized marijuana as a medicine, and more 
states are considering the legalization of medical marijuana. In 1996, California became 
the first state in the United States to legalize medical marijuana use when it passed the 
                                                          
1
 In State v. Diana, a man convicted of marijuana possession was allowed to establish that 
marijuana had a beneficial effect on the symptoms of multiple sclerosis (State, 1979). In United 
States v. Randall, the defendant grew marijuana plants to treat his glaucoma (United States, 1976). 
In Jenks v. State, a couple from Florida was charged with cultivating marijuana plants in their 
home to treat their AIDS-related symptoms (Jenks, 1991). In all these legal cases, the court 
acknowledged the special importance of the defendants’ right to preserve and protect their own 
health and bodies.  
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Compassionate Use Act and removed criminal penalties for using, possessing, and 
cultivating medical marijuana. People are allowed wide latitude for its use, with 
permission from their physicians or healthcare professionals. They can use medical 
marijuana for any serious medical illnesses or any other illness for which marijuana 
provides relief, including emotional conditions (O’Connell & Bou-Matar, 2007). 
Maryland recently became the 21st state, along with the District of Columbia, to enact a 
medical marijuana law. More states, including New York and Pennsylvania, have also 
recently considered medical marijuana legalization (ProCon.org, 2014).  
States have adopted medical marijuana laws with their own specific restrictions in 
terms of qualifying clinical conditions, possession limitations, and registration fees. For 
example, states such as Connecticut, Delaware, New Mexico, and Oregon allow the use 
of medical marijuana to treat mental illnesses (e.g., PTSD), whereas others only allow it 
for physical symptom relief. Possession limits vary from 1 ounce and 6 plants in Alaska 
to 24 ounces and 24 plants in Oregon. The registration fees also differ from no cost in 
New Mexico to $200 in New Jersey. Six states—Arizona, Maine, Michigan, Nevada, 
New Hampshire, and Rhode Island—accept other states’ registry ID cards. Medical 
marijuana laws might vary, but the states do share some common regulations. For 
example, all states require dispensaries to install specific security equipment to deter and 
prevent unauthorized access to medical marijuana, and juvenile patients have to have a 
designated caregiver, who is at least 21 years old, who can assist with patients’ medical 
use of marijuana.  
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In November 2012, Washington and Colorado passed voter-initiated legalization 
of recreational marijuana use (Room, 2013). Adults 21 years old or older can obtain 
marijuana in both states without legal restrictions. Although some efforts in both states 
have sought to prevent potential risks associated with marijuana use, the subject remains 
a hot topic for debate. Moreover, it is unclear whether recent marijuana legalization will 
decrease or increase crime rates.     
Medical Marijuana in Arizona 
In November 2010, Arizona passed medical marijuana legislation, becoming the 
fourteenth state to adopt a medical marijuana law. The Arizona Department of Health 
Services (ADHS) published it final rules, and the Medical Marijuana Act went into effect 
in 2011. In December 2012, the first dispensary opened. Arizona requires that individuals 
who want to obtain medical marijuana apply for certification or a registry identification 
card (ADHS, 2013). The Arizona Medical Marijuana Act also limits the number of 
dispensaries and has the support of the various medical boards.  
ADHS is responsible for issuing registry identification cards for qualifying 
patients. Medical marijuana patients must have written certification from two separate 
physicians confirming diagnosis of the patient’s qualifying debilitating medical condition, 
which must include one of the following illnesses: cancer, glaucoma, positive status for 
human immunodeficiency virus, AIDS, hepatitis C, amyotrophic lateral sclerosis, 
Crohn’s disease, agitation of Alzheimer’s disease, cachexia, chronic pain, nausea, 
seizures, and muscle spasms (ADHS, 2013). According to the Arizona Medical 
Marijuana Act (AMMA) end of year report, as of 2014, Arizona had 50,073 active 
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cardholders: 48,301 are qualifying patients, 597 are designated caregivers, and 1,175 are 
dispensary agents (ADHS, 2014).  
Qualifying patients are allowed to obtain 2.5 ounces of marijuana every 14 
calendar days from a licensed dispensary. They can grow their own marijuana (up to 12 
plants) in an enclosed, locked facility if they live more than 25 miles from a licensed 
dispensary. As of 2014, 4,323 qualifying patients and 402 designated caregivers were 
authorized to cultivate marijuana. They also can “give” (cannot receive any compensation) 
usable marijuana and marijuana plants to dispensaries (ADHS, 2013).   
General Characteristics of Medical Marijuana Users 
In the United States, individuals who want to use medical marijuana legally must 
have a diagnosis from a physician or health professional and must be registered for a 
medical marijuana ID card (Kleber & Dupont, 2012). These individuals, for the purpose 
of this manuscript, are recognized as “authorized medical marijuana users.” Some people 
use medical marijuana for medical or recreational purposes, without a medical marijuana 
identification card. These individuals are called “non-authorized medical marijuana users” 
in the present study. No studies have distinguished the characteristics of authorized 
medical marijuana users and non-authorized medical marijuana users, and few studies 
have reported general characteristics among those who use medical marijuana. In prior 
population research, Ogborne, Smart, and Adlaf (2000) reported demographic differences 
among three groups of people: those who have not used marijuana in the previous year, 
those who use it only non-medically, and those who reported medical use. The authors 
conducted the study from a general population survey with 2,508 adult participants from 
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Ontario, Canada. Ontario City allows people to smoke or grow marijuana if they have an 
authorized medical marijuana license. However, no information was provided regarding 
whether participants in their sample obtained a medical marijuana ID card or not. The 
results indicated that those who use marijuana for any reason tended to be male and 
younger compared to non-users, but there were other no significant differences between 
people who use marijuana non-medically and who use marijuana medically (Ogborne et 
al., 2000).  
Reinarman, Nunberg, Lanthier, and Heddleston (2011) compared characteristics 
of medical marijuana patients from nine medical marijuana assessment clinics operating 
in California, to the United States Census data from California. Their sample of medical 
marijuana users was younger on average (approximately 28% of people were 25 to 34 
years old), reported slightly more years of formal education (most were high school 
graduates (42.2%), and was more often employed (64.8%). However, the authors did not 
indicate whether they excluded people who have a medical marijuana ID card or who use 
marijuana for medical purposes. If a significant number of people included in the sample 
are also included the United States Census of California, the result could be contaminated. 
In terms of medical marijuana consumption among medical marijuana patients, 67% of 
patients reported using medical marijuana daily while half (52.9%) reported using one or 
two times per day. Amounts of usage per week varied. Patients reported more than one 
therapeutic benefit of medical marijuana; relief of pain, muscle spasms, headache, and 
anxiety, as well as improved sleep and relaxation were the most common answers. 
Physicians reported that back and neck pain - followed by sleep disorders, 
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anxiety/depression, muscle spasms, and arthritis - were the most frequent conditions as 
reason for approving medical patient identification cards.  
The Arizona Medical Marijuana Program reports demographic information on 
48,301 active cardholders (ADHS, 2014) based on data collected between April 14, 2011, 
and March 28, 2014. A majority of the qualifying patients were male (69.5%; n = 33,568). 
Most of the qualifying patients were between 18 and 30 years old (24.4%; n = 11,764) 
and 51 and 60 years old (21.5%; n = 10,389); females were more likely to be older 
compared to males. During the study period, approximately 8.9% of the qualifying 
patients (n = 4,323) cultivated medical marijuana.   
Some anecdotal evidence suggests that people who use marijuana for medical 
purposes are different from those who use it for recreational purposes. First, medical 
marijuana users and recreational marijuana users have different goals of consumption for 
using marijuana. When marijuana is used for recreational purposes, individuals might do 
so to achieve psychological excitement and to get high (Bostwick, 2012). Recreational 
marijuana users often report subjective feelings of euphoria, exhilaration, good will, and 
empathy from marijuana use (Gieringer, Rosenthal, & Carter, 2008), and they seek to use 
marijuana to obtain these feelings. On the other hand, the fundamental motivation of 
medical marijuana users is symptom relief. In prior research, Harris, Jones, Shank, Nath, 
Fernandez, Goldstein, and Mendelson (2000) interviewed 100 members of the Cannabis 
Cultivator’s Club (CCC), a major dispenser of medical marijuana in San Francisco. Fifty-
nine percent of the participants reported that they were using marijuana for medical 
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purposes related to appetite stimulation, nausea, fatigue, lethargy, diarrhea, neuropathic 
pain, and insomnia.  
Second, medical marijuana users and recreational marijuana users differ in the 
amount of marijuana usage. People who use marijuana recreationally tend to use large 
doses of marijuana over long periods of time for its psychotropic effect (Mikos, 2009). 
They often lack control in their use and face adverse personal consequences, such as 
financial crisis and criminal involvement (Bennett et al., 2008). Clinical and 
epidemiological evidence shows that a marijuana use disorder can occur in heavy, 
chronic users, and epidemiological data from a national study indicate that about 10% of 
regular marijuana users become addicted to it (Mikos, 2009). However, people who use 
marijuana for medical purposes generally only consume doses sufficient to produce the 
desired clinical effect and only for as long as is medically necessary (Bostwick, 2012). In 
addition, states that have passed medical marijuana laws have implemented restrictions 
on its use. For example, in Arizona, medical marijuana users can only obtain 2.5 ounces 
of marijuana every 14 calendar days (ADHS, 2013).   
Third, patterns in marijuana ingestion differ between recreational marijuana users 
and medical marijuana users. Generally, most people use marijuana by smoking the dried 
leaves, flowers, or resin in hand-rolled marijuana cigarettes or water pipes (Hall & 
Degenhardt, 2003). However, smoking is typically not accepted for medical use. The 
Food and Drug Administration (FDA) does not approve smoking medical marijuana 
because this type of ingestion can result in negative health consequences. For example, 
smoking can deliver various confounding chemicals, including other biologically toxic 
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substances, and can cause or worsen respiratory symptoms, such as bronchitis and 
chronic cough (NIDA, 2012). In addition, allowing people to smoke medical marijuana 
can possibly send the wrong message to children that smoking is an appropriate delivery 
method (Hall & Degenhardt, 2003). Due to the risks of smoking, there are alternative 
ways to obtain medical benefits from marijuana, such as through vaporizers, through 
which essential marijuana compounds are extracted and inhaled. Edible marijuana is also 
available. Additionally, it is produced as a pill and used in various foods. These 
alternative ways take effect faster and produce fewer unpleasant reactions (e.g., anxiety, 
irritability, loss of self-control), and the dosage is easier to control (Gieringer et al., 2008). 
Little is known about the population’s characteristics and patterns of marijuana 
consumption among those who use medical marijuana.  
Marijuana and Crime 
In the past 25 years, many studies have revealed a relationship between marijuana 
use and criminal involvement (Bennett et al., 2008). Derzon and Lipsey (1999) 
summarized the findings from 30 independent longitudinal studies on the relationship 
between marijuana use and later delinquency by using meta-analyses. The authors found 
that there was a strong association between marijuana use and problem behavior. In terms 
of a predictive relationship, stronger mean correlations were observed when problem 
behaviors were measured before marijuana use was assessed. However, the study did not 
claim that reducing marijuana use will appreciably decrease delinquent and problem 
behaviors. Bennett et al. (2008) also conducted meta-analyses of the relationship between 
the types of drugs and types of crime. Ten studies compared marijuana use and offending; 
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only four out of ten studies found a significant association between marijuana use and 
crime (mean effect size was approximately 1.5) but the outcome measures varied, 
including property crime (McBride, 1981), conviction (Dembo, Washburn, Wish, 
Schmeidler, Getreu, Berry, Williams, & Blount, 1987), crime (Johnson, Wish, 
Schmeidler, & Huizinga, 1991), and arrest (Webb & Delone, 1996).  
Many studies about the relationship between marijuana use and crime create 
controversial issues on medical marijuana legalization. However, little research has been 
conducted about the relationship between medical marijuana and crime, and there are 
limitations regarding methodology. As a result, the relationship between medical 
marijuana use and criminal involvement has not been substantiated. A few prior studies 
have examined the relationship between medical marijuana and criminal involvement—
namely, violent/property crime, driving under the influence (DUI), illegal drug dealing, 
and other illicit drug use.  
Although no individual-level practical research has been conducted to explore the 
relationship between medical marijuana and violent/property crime, Kepple and 
Freisthler (2012) used an ecological/cross-sectional design to explore the spatial 
relationship between the density of medical marijuana dispensaries and violent/property 
crime rates in the city of Sacramento, California. The study hypothesized that medical 
marijuana dispensaries would be associated with higher crime rates based on the 
assumptions derived from routine activity theory; however, no significant association 
existed between the density of medical marijuana dispensaries and violent and property 
crime rates, when controlling for ecological variables traditionally associated with routine 
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activity theory. Because of the nature of the ecological design, individual-level 
information could not be tested in this study; there is no information about whether 
people frequenting medical marijuana dispensaries would be more likely to be involved 
in violent/property crime or not. 
Second, most states’ medical marijuana laws prohibit qualified patients from 
“engaging in conduct that endangers others” and/or prohibits the use of marijuana while 
operating a motor vehicle (Mostaghim, 2008). In Arizona, medical marijuana cardholders 
who drive after using marijuana can be charged with Driving Under the Influence (DUI) 
(Arizona Capitol Times, 2013). If a driver’s blood level is high enough to charge the 
motorist with DUI of drugs, the card authorizing the use of medical marijuana no longer 
gives the driver protection. No empirical research has been conducted to reveal the 
association between medical marijuana use and DUI. However, Anderson et al. (2011) 
examined the relationship between medical marijuana laws and traffic fatalities using 
state-level data obtained from the Fatality Analysis Reporting System (FARS) between 
1990 and 2009, during which time 13 states enacted a medical marijuana law. They found 
that medical marijuana legalization was associated with a 22% decrease in the rate of 
traffic fatalities. When state and year fixed effects were included and state-level controls 
were added, legalization was associated with a 7.9% decrease in the fatality rate.
2
 Yet this 
study could not explain individuals’ driving behavior under the influence by using an 
                                                          
2
 This study explained the negative relationship between medical marijuana legalization and 
traffic fatalities by hypothesizing that marijuana and alcohol are substitutes. The authors 
examined the relationship between medical marijuana laws and alcohol consumption and found 
that the legalization is associated with a 25% decrease in drinking and a 5% drop in beer sales.  
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indirect measure of DUI (i.e., traffic fatality rate); therefore, potential risk on the road by 
medical marijuana users was not substantiated.  
Third, in terms of the relationship between medical marijuana use and illegal drug 
dealing, O’Brien (2013) conducted qualitative research with undergraduate college 
students who have a medical marijuana ID card. The author suggested using general 
strain theory to explain crime control with medical marijuana. According to general strain 
theory, individuals try to avoid painful or aversive situations and frustration through pain-
avoidance behaviors, which might lead to illegal attempts or anger-based delinquency 
(Agnew, 1985a). Based on the assumption of general strain theory, O’Brien (2013) 
argued that individuals with medical marijuana licenses would reduce their criminal 
involvement because of the reduced strain caused by the uncertainty of product quality 
and avoidance of the insecurity of the illicit drug marketplace.  
Unlicensed drug transactions in the illicit drug marketplace are unpredictable and 
unregulated. These unstable situations can incur the risk of criminal sanctions (e.g., 
arrests, fines, and potential incarceration for marijuana possession), as well as 
unpredictable quality of marijuana. Yet as medical marijuana users, individuals can avoid 
these unpleasant situations by acquiring marijuana from regulated industries and getting 
honest information from professionals. Medical marijuana legalization has reduced the 
“strain of a substantial segment of society by institutionalizing acceptable and lawful 
means of accessing marijuana” (O’Brien, 2013, p. 438).  
Thurstone, Lieberman, and Schmiege (2011) examined the prevalence of medical 
marijuana use among 80 adolescents in a substance treatment program in Denver, 
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Colorado. Although medical marijuana is not permitted for adolescents, there are 
concerns about the shift in availability having potential impacts on adolescents. The study 
found that 48.8% of the participants reported having obtained marijuana from someone 
with a medical marijuana ID card. In addition, these adolescents, compared to those 
adolescents who had not acquired marijuana in this manner, reported a significantly 
greater availability of marijuana, fewer friends who disapproved of regular marijuana use, 
more frequent marijuana use, and more substance use problems. Medical marijuana ID 
card holders might play a role as a safe supply source for teenagers because people with 
medical marijuana ID cards can legitimately acquire marijuana for any purpose; this 
could lead to more negative consequences, such as adolescents’ substance abuse or DUI. 
However, the data used in this study were limited to a small number of adolescents. As 
no participants with a medical marijuana ID card were included in the study, the authors 
could not examine actual criminal involvement of medical marijuana ID card holders.       
Finally, people have sought to ban medical marijuana legislation because they 
perceive marijuana as a gateway drug for other illegal drugs, such as cocaine, heroin, and 
methamphetamines (DuPont, 1984). Prior studies have found a positive relationship 
between marijuana and other illegal drug use (Kandel & Faust, 1975; Yamaguchi & 
Kandel, 1984a, 1984b; Kandel, Davies, Karus, & Yamaguchi, 1986; Kandel, Yamaguchi, 
& Chen, 1992; Stenbacka, Alleback, & Romelsjo, 1993; Fergusson & Horwood, 2000). 
However, available research on the relationship between medical marijuana and other 
drug use is limited and has produced mixed findings. Ogborne et al. (2000) reported that 
medical marijuana users are more likely to have alcohol problems and use cocaine than 
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recreational marijuana users and non-marijuana users. This study has methodological 
limitations because it used a general population survey from Ontario, Canada, and simply 
compared self-reported answers without controlling for other confounding factors that 
could contribute to respondents’ alcohol and cocaine use. On the other hand, Reinarman 
et al. (2011) found that medical marijuana users show significant lower prevalence of 
alcohol, cocaine, heroin, methamphetamine, and other opiate use. The authors compared 
1,746 patients from medical marijuana evaluation clinics to the United States Census of 
California. As they conducted their study in a clinical setting, patients might have under-
reported their illegal drug use out of fear that their answers could affect their ability to 
keep their medical marijuana ID cards.  
Current Focus 
Although the previously discussed research examined the relationship between 
medical marijuana use and criminal involvement, they have limitations regarding sample 
and methodology. Moreover, little research has focused on this relationship. The present 
study fills these gaps by formally comparing authorized medical marijuana users with 
several comparison groups (e.g., non-authorized medical marijuana users, non-authorized 
marijuana user, and non-marijuana users) among the at-risk adult population. The 
purpose of this study is to explore the characteristics of medical marijuana users and to 
examine the relationship between the types of self-reported medical marijuana use and 
criminal involvement among recently booked arrestees in Maricopa County in Arizona. 
More specifically, this study examines three areas related to medical marijuana use 
among a sample of adult arrestees in Maricopa County: 
                                                                            
    
22 
 
(1) What are the general characteristics and marijuana acquisition patterns of 
authorized medical marijuana users, compared to non-authorized medical 
marijuana users, non-authorized marijuana users, and non-marijuana users?;  
(2) Is there a relationship between the types of self-reported marijuana use 
(authorized medical marijuana users, non-authorized medical marijuana user, 
non-authorized marijuana user, and non-marijuana users) and criminal 
involvement (property crime, violent crime, driving under the influence, and 
drug selling/making)?; and 
(3) Is there a relationship between the types of self-reported marijuana use 
(authorized medical marijuana users, non-authorized medical marijuana user, 
non-authorized marijuana user, and non-marijuana users) and substance use 
(e.g., alcohol, cocaine, opiates, and methamphetamines)? 
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CHAPTER 3 
METHOD 
Data 
The data used in this study were collected through the Arizona Arrestee Reporting 
Information Network (AARIN), which was established in January 2007 and funded by 
the Maricopa County Board of Supervisors. The AARIN project was modeled after the 
Arrestee Drug Abuse Monitoring (ADAM) project which was sponsored by the National 
Institute of Justice. The ADAM project ran in 35 sites across the United States to monitor 
drug use trends and other risky behaviors among recently booked arrestees (National 
Institute of Justice, 2013). The AARIN project adopted the methodology used by ADAM 
and focused on collecting data to assess the impact of substance use and drug related 
activities of arrestees in Maricopa County, Arizona. It provides information on drug 
trends, criminal involvement, victimization, and other characteristics of interest among 
arrestees, in addition to the urine specimens.  
The data used in this study were collected between September 2012 and June 
2013, from 2,656 people who were recently booked as adult arrestees in Maricopa 
County. The data were collected on a quarterly basis - over a continuous two week period 
- from Maricopa County Central Intake (4
th 
Avenue Jail). In order to ensure 
representativeness of the results for the population of arrestees in Maricopa County, the 
AARIN program gathered data through stock and flow processes in any given 24-hour 
period. Interviews were conducted for eight hours per day during the data collection 
period; the stock samples were selected from a list of all bookings processed during non-
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data collection hours. The flow samples include those randomly selected arrestees who 
were booked during the eight-hour period data collection.  
During the data collection periods, participants completed face-to-face interviews 
with professionally trained interviewers; the interviews were conducted daily during the 
eight-hour interview period. Each interview took approximately one hour. The core 
survey instrument included various special topics as well as demographics/background 
information. This study focused on the demographic characteristics (e.g., gender, age, 
race/ethnicity), situational characteristics (e.g., educational level, economic status, mental 
health status), self-reported number of prior arrests, drug use (including urinalyses), 
criminal involvement, and type of marijuana use.  
Sample 
A total of 3,656 arrestees were selected as potential respondents in AARIN, but 
some of them were ineligible or unavailable to participate. Arrestees who had been in 
custody for 48 hours or less were eligible to participate in the AARIN project; however, 
arrestees who constituted a threat to jail personnel and/or interview staff were excluded 
from participation (n = 558). Participation was determined by voluntary agreement; of the 
3,098 eligible arrestees, 87.5% agreed to participate in the study and completed the 
interview (n = 2,706). In addition, respondents who did not provide answers to the key 
questions of this study (e.g., whether they have medical marijuana ID card or use 
(medical) marijuana in the past 30 days) were excluded from this study (n = 50).
3
 A total 
                                                          
3
 This study excluded participants with a medical marijuana ID card issued by the State of 
Arizona who did not report medical marijuana use in the previous 30 days (n = 15) and 
participants who did not answer the questions for determining their type of marijuana use (n = 35).  
                                                                            
    
25 
 
of 2,656 cases were used for this study, and 94% of these respondents provided a urine 
specimen (n = 2,485).  
The descriptive characteristics of the respondents are presented in Table 4. The 
sample consists of more males (75.94%; n = 2,017) than females (24.06%; n = 639). With 
regard to ethnic background, 47.55% of the sample were White (n = 1,263); 29.67% were 
Hispanic or Latino (n = 788); 14.61% were African American (n = 388); and 8.17% self-
identified as “Other” (n = 217). Age ranged from 18 to 75 years (average age = 32.79). 
Approximately 68% of the respondents were high school graduates (n = 1,804). In terms 
of income source, most of the respondents reported having legal income at the time they 
were arrested (78.40%; n = 2,011), whereas 11.70% reported illegal income (n = 300) 
and 9.90% reported no income (n = 254). The sample included a small number of current 
gang members (4.36%; n = 115). Approximately 57% of respondents indicated either 
substance use disorder or mental disorder risks (n = 1,500). Sample respondents had been 
arrested on average one time in the preceding 12 months. Approximately 40% of 
respondents had medical insurance (41.64%; n = 1,106). 
Variables 
Dependent variable. Self-reported criminal involvement and drug use of 
arrestees served as the dependent variables in this study. Self-reported criminal 
involvement comprised four categories: property crime, violent crime, DUI, and drug 
selling/making. Self-reported drug use consisted of three categories: cocaine, opiates, and 
methamphetamine. A description of each construct is provided in Table 1. 
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Table 1. Descriptive Statistics for Dependent Variables (Criminal Involvement and Substance Use) 
Variable Code n (%) 
Property Crimes   
Have you written/drawn graffiti on neighborhood houses, 
walls, schools, stores, etc.? 
1 = Yes; 0 = No 61 (2.3%) 
Have you destroyed property worth LESS than $250? 1 = Yes; 0 = No 157 (5.9%) 
Have you destroyed property worth MORE than $250? 1 = Yes; 0 = No 104 (3.9%) 
Have you stolen property worth LESS than $1,000 (including 
shoplifting)? 
1 = Yes; 0 = No 353 (13.3%) 
Have you stolen property worth MORE than $1,000 
(including shoplifting)? 
1 = Yes; 0 = No 105 (4.0%) 
Have you stolen a car or other motor vehicle? 1 = Yes; 0 = No 54 (2.0%) 
Have you broken into a house, store, or building to commit a 
theft? 
1 = Yes; 0 = No 102(3.8%) 
Have you used someone’s ID or identity to commit theft, 
forgery, or fraud? 
1 = Yes; 0 = No 50 (1.9%) 
Violent Crimes   
Have you threatened to attack someone without using a 
weapon? 
1 = Yes; 0 = No 406 (15.3%) 
Have you threatened to attack someone using a weapon? 1 = Yes; 0 = No 171 (6.4%) 
Have you robbed someone by force or by threat of force 
without using a weapon? 
1 = Yes; 0 = No 61 (2.3%) 
Have you robbed someone by force or by threat of force using 
a weapon? 
1 = Yes; 0 = No 48 (1.8%) 
Have you attacked, assaulted or beaten-up someone without 
using a weapon? 
1 = Yes; 0 = No 333 (12.5%) 
Have you attacked, assaulted or beaten-up someone using a 
weapon? 
1 = Yes; 0 = No 79 (3.0%) 
Have you participated in a drive-by shooting? 1 = Yes; 0 = No 11(0.4%) 
Have you possessed a firearm while prohibited (felony 
conviction, probation, underage, etc.)? 
1 = Yes; 0 = No 164 (6.2%) 
Have you committed domestic violence (including assault, 
disorderly conduct, criminal damage, etc.)? 
1 = Yes; 0 = No 348 (13.1%) 
DUI   
Have you driven under the influence of alcohol? 1 = Yes; 0 = No 512 (19.3%) 
Have you driven under the influence of drugs (not including 
alcohol)? 
1 = Yes; 0 = No 561 (21.1%) 
Drug selling/making   
Have you sold or made drugs? 1 = Yes; 0 = No 310 (11.7%) 
Substance Use   
Have you used alcohol during the last 30 days? 
Have you used powder cocaine during the last 30 days? 
1 = Yes; 0 = No 
1 = Yes; 0 = No 
1,763 (66.53%) 
184 (6.9%) 
Have you used opiate during the last 30 days? 1 = Yes; 0 = No 232 (8.7%) 
Have you used methamphetamine during the last 30 days? 1 = Yes; 0 = No 696 (26.2%) 
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Criminal involvement. All questions pertained to crimes that the respondents may 
have committed in the past 12 months and the responses were captured using 
dichotomous indicators. First, property crimes included graffiti, property, theft, burglary 
and identity theft. Respondents were asked eight questions and individuals who answered 
“yes” to one out of the eight questions were coded as 1 (1 = committed one or more 
property crimes; 0 = did not commit property crime): “Have you written/drawn graffiti on 
neighborhood houses, walls, schools, stores, etc.?”(2.3%; n = 61), “Have you destroyed 
property worth LESS than $250?” (5.9%; n = 157), “Have you destroyed property worth 
MORE than $250?” (3.9%; n = 104), “Have you stolen property worth LESS than $1,000 
(including shoplifting)?” (13.3%; n = 353), “Have you stolen property worth MORE than 
$1,000 (including shoplifting)?” (4.0%; n = 105), “Have you stolen a car or other motor 
vehicle?” (2.0%; n = 54), “Have you broken into a house, store, or building to commit a 
theft?” (3.8%; n = 102), and “Have you used someone’s ID or identity to commit theft, 
forgery, or fraud?” (1.9%; n = 50). 
Second, violent crimes included threat, robbery, assault, possession of a firearm, 
and domestic violence
4
. Respondents were asked nine questions and individuals who 
answered “yes” to one out of the nine questions were coded as 1 (1 = committed one or 
more violent crimes; 0 = did not commit violent crime): “Have you threatened to attack 
someone without using a weapon?” (15.3%; n = 406), “Have you threatened to attack 
someone using a weapon?” (6.4%; n = 171), “Have you robbed someone by force or by 
                                                          
4
 In this study, domestic violence means that a pattern of assaultive and/or coercive behaviors, 
including physical, sexual, and psychological attacks in a household, not limited to violence 
against women.  
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threat of force without using a weapon?” (2.3%; n = 61), “Have you robbed someone by 
force or by threat of force using a weapon?” (1.8%; n = 48), “Have you attacked, 
assaulted or beaten-up someone without using a weapon?” (12.5%; n = 333), “Have you 
attacked, assaulted or beaten-up someone using a weapon?” (3.0%; n = 79), “Have you 
participated in a drive-by shooting?” (0.4%; n = 11), “Have you possessed a firearm 
while prohibited (felony conviction, probation, underage, etc.)?” (6.2%; n = 164), and 
“Have you committed domestic violence (including assault, disorderly conduct, criminal 
damage, etc.)?” (13.1%; n = 348).  
Third, in order to capture the respondents’ DUI history, they were asked “Have 
you driven under the influence of alcohol?” (19.3%; n = 512) and “Have you driven 
under the influence of drugs (not including alcohol)?” (21.1%; n = 561). Individuals who 
answered “yes” to either one of these question were coded as 1 (1 = committed one or 
more DUI’s; 0 = did not commit DUI). Last, respondents were asked “Have you sold or 
made drugs?” (11.7%; n = 310) to determine their criminal involvement in Drug 
selling/making. If arrestees answer “yes” to this question, they were coded as 1 (1 = sold 
or made drugs one or more times; 0 = did not sale or make drugs). 
Substance use. In terms of respondents’ substance use, the study included four 
types of substances: alcohol, cocaine, opiate, and methamphetamine. All questions 
obtained information regarding drug use by the respondents may have used in the past 30 
days, and the responses were captured using dichotomous indicators. The respondents 
were asked “Have you used alcohol during the last 30 days?” to determine alcohol use (1 
= yes; 66.53%, n = 1,763), “Have you used powder cocaine during the last 30 days?” to 
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determine cocaine use (1 = yes; 6.9%, n = 184), “Have you used an opiate during the last 
30 days?” to determine opiate use (1 = yes; 8.7%, n = 232), and “Have you used 
methamphetamine during the last 30 days?” to determine meth use (1 = yes; 26.2%; n = 
696). 
Independent variables. Types of self-reported marijuana use served as 
independent variables and are presented in Table 2: authorized medical marijuana user, 
non-authorized medical marijuana user, non-authorized marijuana user, and non-user. 
Respondents were asked three questions to be categorized into the four groups: “Did you 
ever have a medical marijuana card from the State of Arizona?”, “Have you used medical 
marijuana in the State of Arizona in the past 30 days?”, and “In the past 30 days, how 
many days did you use marijuana?”   
First, if respondents had a medical marijuana ID card issued by the state of 
Arizona and reported medical marijuana use in the past 30 days, they would be 
categorized as an authorized medical marijuana user (AuMM user; 2.3%; n = 60). Second, 
respondents who reported using medical marijuana in the past 30 days without a medical 
marijuana ID card were coded as 1 for a non-authorized medical marijuana user 
(NonAuMM user; 10.9%; n = 290). Third, if respondents without a medical marijuana ID 
card did not report medical marijuana use during the past 30 days, but reported marijuana 
use, were be coded as 1 for a non-authorized marijuana user (NonAuM user; 30.4%; n = 
808). Last, respondents who reported neither medical marijuana use nor marijuana use in 
the past 30 days without a medical marijuana ID card were coded as 1 for a non-user 
(Non-user; 56.4%; n = 1,498).  
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Table 2. Categories of (Medical) Marijuana Users 
 
Authorized 
medical 
marijuana user 
(n=60; 2.2%) 
Non-authorized 
medical 
marijuana user 
(n=290; 10.7%) 
Non-
authorized 
marijuana 
user 
(n=808; 29.8%) 
Non-users 
(n=1,498; 55.2%) 
 
Medical marijuana ID 
card 
Yes No No No 
Medical marijuana 
use in the past 30days 
Yes Yes No No 
Marijuana use in the 
past 30 days 
- - Yes No 
 
Three dummy variables were used to reflect respondents’ marijuana use: non-
authorized medical marijuana user (NonAuMM user; 1 = yes), non-marijuana user 
(NonAuM user; 1 = yes), and non-user (Non-user; 1 = yes). The reference category was 
authorized medical marijuana user (AuMM users, 1 = yes). 
Control variables. To guard against potential spuriousness, nine control variables 
were included in the present study. A dummy variable was used to reflect respondents’ 
mental health risk (1 = yes). Illicit drug use has been associated with violent behavior in 
past research, and some studies have shown that people who have mental disorders are 
more likely to commit violent acts than people who do not have any mental problems 
(Hiday, 2006; Elbogin & Johnson, 2009). If respondents were recognized as having 
alcohol/drug use disorder risk or mental disorder risk, they were coded as 1. Respondents 
were asked four questions to determine their mental disorder risk and seven questions 
which indicated criteria for substance abuse and dependence
5
. If respondents answer  
                                                          
5
 The questions were presented by the DSMIV-TR criteria for substance use disorders. According 
to DSMIV-TR, if a person meets one or more of those criteria, he or she would be diagnosed as 
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Table 3. Descriptive Statistics for Mental Health Risk Variables 
Variable Code n (%) 
Mental Disorder Risk   
Have you been told by a counselor, social worker, or doctor 
that you have a mental illness, or emotional problem in the 
past 12 months? 
1 = Yes; 0 = No 428 (16.1%) 
Have you been treated by a counselor, social worker, or 
doctor for a mental health problem in the past 12 months?  
1 = Yes; 0 = No 373 (14.0%) 
Have you been given or prescribed medication for a mental 
health, emotional, or psychiatric problem in the past 12 
months? 
1 = Yes; 0 = No 359 (13.5%) 
Have you been hospitalized for a mental health problem in 
the past 12 months? 
1 = Yes; 0 = No 106 (4.0%) 
Substance Use Disorder Risk   
Have you felt sick, shaky, or depressed when you stopped 
drinking or using drugs in the past 12 months? 
1 = Yes; 0 = No 838 (31.6%) 
Does your family or friends complain about your 
involvement with drugs or alcohol in the past 12 months? 
1 = Yes; 0 = No 1,022 (38.5%) 
Have you continued to use alcohol or drugs despite 
problems caused by your use in the past 12 months? 
1 = Yes; 0 = No 1,007 (37.9%) 
Have you engaged in illegal activities in order to obtain 
alcohol or drugs in the past 12 months? 
1 = Yes; 0 = No 539 (20.3%) 
Have you neglected your family because of your alcohol or 
drug use in the past 12 months? 
1 = Yes; 0 = No 769 (29.0%) 
Has there been a time when you needed to increase the 
amount you drink or use more drugs to get the effect you 
want in the past 12 months? 
1 = Yes; 0 = No 794 (29.9%) 
Have you neglected important work, social or recreational 
activities or responsibilities because of your alcohol or drug 
use in the past 12 months? 
1 = Yes; 0 = No 715 (26.9%). 
 
“yes” to one out of 11 questions, they were categorized as having mental health risk. A 
description of each question is provided in Table 3. 
There are four questions to determine whether respondents have mental disorder 
risk or not: “Have you been told by a counselor, social worker, or doctor that you have a 
mental illness or emotional problem in the past 12 months?” (16.1%; n = 428), “Have 
                                                                                                                                                                             
substance abuse. Moreover, if a person meets three or more of those criteria, he or she would be 
diagnosed as substance dependence (APA, 2000). 
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you been treated by a counselor, social worker, or doctor for a mental health problem in 
the past 12 months?” (14.0%; n = 373), “Have you been given or prescribed medication 
for a mental health, emotional, or psychiatric problem in the past 12 months?” (13.5%; n 
= 359), and “Have you been hospitalized for a mental health problem in the past 12 
months?” (4.0%; n = 106). 
For detecting the substance use disorder risk, seven questions were asked: “Have 
you felt sick, shaky, or depressed when you stopped drinking or using drugs in the past 
12 months?” (31.6%; n = 838), “Do your family or friends complain about your 
involvement with drugs or alcohol in the past 12 months?” (38.5%; n = 1,022), “Have 
you continued to use alcohol or drugs despite problems caused by your use in the past 12 
months?” (37.9%; n = 1,007), “Have you engaged in illegal activities in order to obtain 
alcohol or drugs in the past 12 months?” (20.3%; n = 539), “Have you neglected your 
family because of your alcohol or drug use in the past 12 months?” (29.0%; n = 769), 
“Has there been a time when you needed to increase the amount you drink or use more 
drugs to get the effect you want in the past 12 months?” (29.9%; n = 794), and “Have you 
neglected important work, social or recreational activities or responsibilities because of 
your alcohol or drug use in the past 12 months?” (26.9%; n = 715). 
Gang membership was controlled to capture the independent effect of type of self-
reported marijuana use on criminal involvement, and determined by asking the 
respondents if they are currently in a gang. Prior studies have shown that gang 
membership is associated with involvement in crime (Decker & Van Winkle, 1996) and 
drug use (Katz et al., 2005). A dummy variable was used for gang membership (1 = yes). 
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Respondents’ number of prior arrests was also controlled. Prior arrests were measured 
by asking respondents the number of times that they have been arrested in the past 12 
months, and they were coded into a continuous variable. Respondents’ age was measured 
in years. Gender was captured using a dummy variable (1= male). Three dummy 
variables were used to reflect respondents’ race/ethnicity: African American (1 = yes), 
Hispanic (1 = yes) and other (1 = yes). The reference category was White. Educational 
achievement of respondents was coded using a dummy variable (1 = high school 
graduate). Income source was captured through two dummy variables: illegal income (1 
= yes) and no income (1 = yes). The reference group was legal income. To demonstrate 
the respondent’s having medical insurance, a dummy variable was used (1 = yes). 
Analytic Strategy 
Bivariate and multivariate analyses were used in this study. First, chi-square and 
analysis of variance (ANOVA) procedures were used to determine the differences in 
arrestees’ age, gender, race/ethnicity, education attainment, income sources, gang 
membership, mental health risk, prior arrests, and medical insurance among AuMM users, 
NonAuMM users, NonAuM users, and Non-users. Similar procedures were used to 
examine the differences in marijuana acquisition pattern, criminal involvement, and 
substance use among the four groups. In addition, given the dichotomous coding of the 
outcome variables, logistic regression analyses were used to examine the relationship 
between the types of self-reported marijuana use and criminal involvement (four different 
models for property, violent, DUI, and drug selling/making) and other substance use 
(three different models for alcohol, cocaine, opiate, and methamphetamine), holding 
                                                                            
    
34 
 
constant the potential effects of confounding factors, including individual (e.g., age, 
gender, and race/ethnicity) and situational characteristics (e.g., education attainment, 
income sources, gang membership, mental health status, prior arrests, and medical 
insurance).  
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CHAPTER 4 
RESULTS 
Demographic Information 
Table 4 presents the sample characteristics of participants by the types of self-
reported marijuana use. There were more males (AuMM users = 93.33%, NonAuMM 
users = 84.14%, NonAuM users = 77.10%, and Non-users = 73.03%) than females in all 
four groups. Most participants were White (AuMM users = 56.67%, NonAuMM users = 
51.72%, NonAuM users = 48.39%, and Non-users = 45.93%). Non-users were 
significantly older (M = 35.29, SD = 10.96) than the three other groups. The majority of 
all four groups were high school graduates; AuMM users (88.33%) were significantly 
more likely to have graduated high school compared with three other groups (NonAuMM 
users = 66.67%, NonAuM users = 64.71%, and Non-users = 70.08%). Most participants 
reported having legal income; however, AuMM users (20.34%), NonAuMM users 
(27.01%), and Non-users (15.38%) were significantly more likely to report having illegal 
income sources compared with Non-users (6.47%), and NonAuM users (10.77%), and 
Non-users (10.95%) were significantly more likely to report no income compared with 
AuMM uesrs (1.69%) and NonAuMM users (3.65%). In terms of gang membership, 
NonAuMM users (10.18%) were significantly more likely to report being a current gang 
member, followed by NonAuM users (5.24%) and Non-users (2.68%). NonAuMM users 
(76.21%) were significantly more likely to have mental health risks than three other 
groups (AuMM users = 58.33%, NonAuM users = 67.70%, and Non-users = 46.56%). 
Regarding the number of prior arrests, NonAuMM users (M = 1.52, SD = 2.64) and  
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NonAuM users (M = 1.25, SD = 2.35) were significantly more likely to have been 
arrested in the past 12 months compared with Non-users (M = .98, SD = 2.21). AuMM 
users were significantly more likely to have medical insurance (61.67%) and NonAuM 
users were significantly less likely to have medical insurance (37.50%).   
Marijuana Acquisition Pattern 
Table 5 indicates marijuana acquisition patterns by types of self-reported 
marijuana use in the past 30 days. AuMM users (91.53%) and NonAuMM users (91.38%) 
were significantly more likely to acquire any marijuana in the past 30 days. In addition, 
on average, they spent significantly more money on any marijuana in the past 30 days; 
AuMM users spent $497.89 and NonAuMM users spent $267.57. However, Non-users, 
on average, acquired significantly more marijuana in the past 30 days than NonAuMM 
users and NonAuM users; Non-users acquired, on average, 2,072.46 grams, NonAuMM 
users acquired 257.12 grams, and NonAuM users acquired 203.64 grams. Non-users 
acquired more marijuana in the past 30 days compared with other three groups. Post hoc 
analysis suggested that this result was the consequence of some outliers among the Non-
user group. Three respondents reported acquiring more than 1,000 grams of marijuana in 
the past 30 days
6
. Although they did not report marijuana use in the past 30 days, they 
reported that they had sold or made drugs in the past 12 months.   
In terms of marijuana acquisition method, AuMM users reported that they bought 
66.85% of the total marijuana they acquired in the past 30 days and grew their own 
                                                          
6 Each person reported 90,718 grams, 4,989 grams, and 1,814 grams. If these three individuals 
were excluded, the average quantity of marijuana acquired in the past 30 days for Non-users is 
43.47 grams (SD = 149.648) which is lesser than the amounts for three other groups.  
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marijuana about 14.5% of the total marijuana they acquired in the past 30 days. Most of 
the marijuana NonAuMM users acquired was through buying (59.94%) or getting it for 
free (33.47%), and Non-users reported buying 40.86% of the marijuana they acquired and 
reported getting for free 53.43% of the time. AuMM users were significantly more likely 
to acquire marijuana from legal dispensaries (32.45% from legal dispensary in Arizona 
and 8.11% from dispensary in other state) and grow their own (14.72%) compared with 
the three other groups. A small proportion of the NonAuMM group and NonAuM group 
acquired their marijuana from legal dispensaries. NonAuMM user (50.44%), NonAuM 
users (53.71%), and Non-users (64.90%) were significantly more likely to get their 
marijuana directly from friends.    
Criminal Involvement    
Bivariate relationship. Table 6 presents the bivariate relationships between 
criminal involvement and types of self-reported marijuana use. All types of criminal 
involvement are significantly different among the four groups. Non-users were 
significantly less likely to report engaging in all types of crimes, including property 
crimes, violent crimes, DUI, and drug selling/making compared with the three other 
groups. NonAuMM users were significantly more likely to engage in property crimes 
(35.64%) and violent crimes (52.60%) than NonAuM users (property crimes: 28.29% and 
violent crimes: 36.56%). NonAuMM users (52.60%) and NonAuM users (37.42%) were 
significantly more likely to commit DUI than Non-users (22.98%), but the three other 
groups are not significantly different when compared to AuMM users (51.67%). In terms 
of drug selling/making, AuMM users (30.00%) and NonAuMM users (24.22%) were 
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significantly more likely to sell or make drugs compared with NonAuM users (15.76%) 
and Non-users (6.35%). These bivariate relationship tests demonstrate that arrestees who 
are using any types of marijuana were significantly more likely to engage in  types of 
crime.      
 
Table 6.  
Self-Reported Criminal Involvement by Types of Self-reported Marijuana Use (N=2,656) 
  
 
AuMM 
users 
(n=60; 2.2%) 
 
 
NonAuMM 
users 
(n=290; 10.7%) 
 
 
NonAuM 
users 
(n=808; 
29.8%) 
 
 
Non-users 
(n=1,498; 
55.2%) 
 
 
Total 
(n=2,656; 
100%) 
 
Significant 
Contrasts Variables χ
2 
n  
(%) 
 
n  
(%) 
 n  
(%) 
 n  
(%) 
 n  
(%) 
Property crimes 84.15** 
16 
(26.67%) 
 
103 
(35.64%) 
 
228  
(28.29%) 
 
236  
(15.80%) 
 
583  
(22.01%) 
4 < 1; 
4 < 3 <2 
Violent crimes 112.62** 
28 
(46.67%) 
 
152 
(52.60%) 
 
295  
(36.56%) 
 
362  
(24.18%) 
 
837 
 31.55%) 
4 < 1; 
4 < 3 <2 
DUI  134.91** 
31 
(51.67%) 
 
152 
(52.60%) 
 
302  
(37.42%) 
 
344  
(22.98%) 
 
829  
(31.25%) 4 < 2, 3 
Drug selling/making 117.78** 
18 
(30.00%) 
 
70  
(24.22%) 
 
127  
(15.76%) 
 
95  
(6.35%) 
 
310  
(11.69%) 4 < 3 < 1, 2 
 
Notes: Percentage calculated within self-reported (medical) marijuana use. 
Pearson’s Chi-squared test.  
Significant contrast presents among AuMM users (1), NonAuMM users (2), NonAuM users (3), and Non-users (4). 
*p<. 05; **p<.001 (two-tailed test). 
 
Multivariate relationships. Table 7 indicates the multivariate relationship 
between criminal involvement and types of self-reported marijuana use, controlling for 
individual and situational characteristics by using logistic regression. The coefficient (b), 
standard errors (SE), and the odds ratio (OR) are presented for each of the independent 
variables. Several diagnostic tests were performed to determine whether harmful levels of 
collinearity would bias the multivariate parameter estimates in the logistic regression 
models. None of the bivariate correlations between the independent variables and control 
variables exceeded an absolute value of .70 and condition indices failed to approach the 
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commonly used threshold of 30 (Tabachnick & Fidell, 2007)
7
. These diagnostics 
indicated that harmful collinearity is not a concern. All models had significant χ2 values at 
the p < .0001 level for the model-fit diagnosis and the predictive powers of all the models 
were higher than .7, which is considered acceptable discrimination (Hosmer & 
Lemeshow, 2000). Table 7 contains four logistic regression equations. There was no 
significant effect of types of self-reported marijuana use on property crime and violent 
crime, when controlling for other confounding factors
8
. However, Non-users were 
significantly less likely to commit DUI compared with AuMM users (b = -.90, p <.05). 
Being a Non-user decreased the odds of committing DUI by 59% when controlling for 
other factors
9
. Both NonAuM users and Non-users were significantly less likely to 
sell/make drugs than AuMM users (b = -.86, p <.05; b = -1.37, p <.05; respectively).  
                                                          
7
 The variance inflation factors (VIF) were also tested and the results were under 3 except when 
AuMM users used as a reference group. The variance inflation factors were increased to 11.8 
which mean that the standard error for the coefficient of AuMM is 3.4 times as large as it would 
be if AuMM user variable were uncorrelated with other predictor variables. However, none of 
bivariate correlations between independent variables were problematic, and the other collinearity 
diagnosis test, condition indices, shown noncollinearity. The possible explanation of high VIF 
would be the dummy measurement and small sample size (n=60). It is not a problem and can be 
safely ignored when the proportion of cases in the reference category is small so the dummy 
variables have high VIFs (Allison, 2012).     
8
 Additional logistic regressions were run with a different reference group. The results indicated 
that NonAuMM users and NonAuM users were significantly more likely to commit property 
crimes than Non-users (b = .35, p <.05; b = .34, p <.001; respectively). The odds of committing 
property crimes will increase by 42%for being a NonAuMM user and by 40% for being a 
NonAuM user. In terms of violent crime, NonAuMM users were significantly more likely to 
commit violent crimes than NonAuM users and Non-users (b = .44, p <.05; b = .63, p <.001; 
respectively). Being a NonAuMM user will increase the odds of committing violent crime by 55% 
compared with NonAuM user and 88% compared with Non-users.  
9
 Additional logistic regressions were run with Non-users as a reference group. The result 
indicated that NonAuMM users and NonAuM users were significantly more likely to be caught 
by DUI than Non-users (b = .95, p <.001; b = .47, p <.001; respectively). The odds of committing 
DUI will increase by 158%for being a NonAuMM user and by 61% for being a NonAuM user.  
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Table 7.  
The Effect of Types of Self-reported Marijuana Use on Criminal Involvement in the Last 12 Months 
Variables 
Property Crimesa 
 
Violent Crimesa  
 
DUIa  
 
Drug Selling/Makinga 
b (SE) OR  b (SE) OR  b (SE) OR  b (SE) OR 
NonAuMM usersb .36 (.38) 1.43  .23 (.32)  1.26  .04 (.31)  1.05  -.70 (.39)   .49 
NonAuM usersb .35 (.37) 1.42  -.21 (.30)    .81  -.43 (.29)    .65  -.86 (.38)   .42* 
Non-usersb .01 (.36) 1.01  -.40 (.30)    .67  -.90 (.29)    .41*  -1.37 (.38)   .26* 
Gang membership .17 (.23) 1.18  1.24 (.23) 3.47**  .39 (.22)  1.48  .47 (.28) 1.61 
Mental health risk 1.02 (.12) 2.76**  .78 (.10) 2.19**  .78 (.10) 2.19**  1.47 (.20) 4.35** 
Prior arrests .13 (.02) 1.14**  .08 (.02) 1.08**  -.02 (.02)    .98  .02 (.03) 1.02 
Age -.03 (.01) .97**  -.03 (.00) .97**  -.02 (.00)  .98**  -.01 (.01)    .99 
Male .08 (.13) 1.09  .24 (.11)  1.28*  .17 (.11)   1.18  .26 (.18) 1.29 
African American -.27 (.17)   .77  .12 (.14)  1.12  -.43 (.15)    .65*  -.35 (.23) .70 
Hispanic -.08 (.13)   .93   .02 (.12)  1.02  .11 (.11)  1.12  -.02 (.18) .98 
Other -.25 (.21)   .78  -.10 (.18)    .90  .48 (.17)  1.62*  -.72 (.32) .48* 
High school graduate .14 (.12) 1.16  .24 (.11)  1.27*  .62 (.11) 1.87**  .36 (.17) 1.43* 
Illegal income  1.34 (.15) 3.82**  .76 (.14)  2.13**  .48 (.14)  1.62*  2.15 (.16) 8.55** 
No income .09 (.18) 1.10  -.14 (.16)    .87  -.89 (.20)    .41**  .02 (.29)  1.02 
Medical insurance .28 (.11) 1.33*  .17 (.10)   1.18  .10 (.10)   1.11  -.04 (.15) .96 
Intercept -1.64 (.44)   -.76 (.37)     -.52 (.36)   -2.51 (.51)  
 
Model χ2 
McFadden’s R2 
 
400.22** 
.15 
 
 
337.40** 
.11 
 
 
330.34** 
. 11 
  
439.53** 
.25 
N 2,514  2,518  2,518  2,517 
Notes: Entries are unstandardized coefficients (b), standard errors in parentheses, and odds ratios. 
a Logistic regression equation. 
b AuMM users are the reference group. 
*p<. 05; **p<.001 (two-tailed test). 
 
The odds of selling/making drugs decreased by 58% for NonAuM users and by 74% for 
Non- users when controlling for other factors
10
. In terms of effects of control variables on 
                                                          
10
 Additional logistic regression results indicated that NonAuMM and NonAuM users were 
significantly more likely to sell/make drugs than Non-users (b = .66, p <.05; b = .51, p <.05; 
respectively). The odds of selling/making drugs will increase by 94% for being a NonAuMM user 
and by 66% for being a NonAuM user.  
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criminal involvement, having mental health risk was significantly associated with all four 
types of criminal involvement. Regarding income source, people who have illegal income 
sources were significantly more likely to self-report committing all types of crime.   
 
 
Figure 1. Probability of Criminal Involvement by Different Types of Self-reported 
Marijuana Use among Arrestees in Maricopa County, AZ. 
 
To illustrate the unit effects of independent variables on the probability of 
criminal involvement in the past 12 months, Figure 1 shows the estimated probability of 
criminal involvement by different types of self-reported marijuana use. A base person for 
comparison is a white female having a legal income source, without mental health risk, at 
the mean of age and number of prior arrests, no high school diploma, no medical 
insurance, and not a current gang member. Figure 1 shows that being a NonAuMM user 
increases the probability of involvement in property crime by 3% during the previous 12 
0.00% 
4.69% 
12.25% 
4.19% 
3.00% 
8.04% 
13.15% 
1.37% 
2.90% 
2.06% 
5.48% 
0.98% 
0.07% 0.00% 0.00% 0.00% 
Property crime Violent crime DUI Drug selling/making
Probability of Criminal Involvement  
by Different Types of Self-reported Marijuana Use  
Among Arrestees in Maricopa County, AZ  
AuMM users NonAuMM users NonAuM users Non users
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months, and 2.9% for a NonAuM user. In terms of committing violent crime, being a 
NonAuMM user increases the probability of involvement in violent crime by 8% and 
4.69% for an AuMM user. Being a NonAuMM user (13.15%), AuMM user (12.25%), 
and NonAuM user (5.48%) increases the probability of committing DUI during the past 
12 months. Last, being an AuMM user increases the probability of selling/making drugs 
by approximately 4% during the previous 12 months.  
Substance Use    
Bivariate relationship. Table 8 presents bivariate relationships between 
substance use (i.e., alcohol, cocaine, opiate, and methamphetamine) and types of self-
reported marijuana use. Substance use was captured in three ways: whether the 
respondent self-reported using substances in the past 12 months, in the past 30 days, and 
tested positive for substances through an urinalyses test. First, there was significant 
difference in self-reported alcohol use in the past 12 months and in the past 30 days by 
types of self-reported marijuana use, but there was no significant significant difference in 
urinalysis for alcohol. NonAuMM users and NonAuM users were significantly more 
likely to drink alcohol than Non-users. Second, there was significant difference in self-
reported cocaine use in the past 12 months and in the past 30 days by types of self-
reported marijuana use, but there was no significant difference in urinalysis for cocaine. 
AuMM users and NonAuMM users were significantly more likely to use cocaine than 
Non-users. Third, self-report and urinalysis for opiate use was significantly different 
among four groups. AuMM users, NonAuMM users, and NonAuM users were 
significantly more likely to self-report using opiates in the past 12 months and were  
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Table 8. Self-reported Substance Use and Urinalyses Results by Types of Self-reported Marijuana 
Use (N=2,656) 
  AuMM 
users 
(n=60; 2.2%) 
 
NonAuMM 
users 
(n=290; 10.7%) 
 
NonAuM 
users 
(n=808; 
29.8%) 
 
Non-
users 
(n=1,498; 
55.2%) 
 
Total 
(n=2,656; 
100%) 
 
Significant 
Contrasts 
Variables χ2 n (%)  n (%)  n (%)  n (%)  n (%) 
Alcohol            
Past 12 months 66.58** 
50 
(83.33%) 
 249 
(85.86%) 
 686 
(84.90%) 
 1,075 
(71.76%) 
 2,060 
(77.56%) 4 < 2, 3 
Past 30 days 72.29** 
41 
(68.33%) 
 223 
(76.90%) 
 607 
(75.22%) 
 892 
(59.75%) 
 1,763 
(66.53%) 4 < 2, 3 
Positive UA 6.73 
3 
(5.36%) 
 
31 
(11.19%) 
 
70 
(9.15%) 
 
170 
(12.26%) 
 
274 
(11.03%) - 
Cocaine            
  Past 12 months 96.47** 
12 
(20.00%) 
 
73 
 (25.17%) 
 
114  
(14.11%) 
 
102  
(6.81%) 
 
301  
(11.33%) 
4 < 1; 
4 < 3 <2 
  Past 30 days 92.35** 
6  
(10.00%) 
 
51  
(17.59%) 
 
78  
(9.65%) 
 
49  
(3.27%) 
 
184  
(6.93%) 
4 < 1; 
4 < 3 <2 
  Positive UA   4.34 
2  
(3.57%) 
 
28  
(10.11%) 
 
69  
(9.02%) 
 
105  
(7.57%) 
 
204  
(8.21%) 
- 
Opiate            
  Past 12 months 45.91** 
13 
(21.67%) 
 
51  
(17.59%) 
 
115 
 (14.23%) 
 
114  
(7.61%) 
 
293  
(11.03%) 
4 < 1, 2, 3 
  Past 30 days 29.25** 
7  
(11.67%) 
 
42  
(14.48%) 
 
89  
(11.01%) 
 
94  
(6.28%) 
 
232  
(8.74%) 
4 < 2, 3 
  Positive UA  17.00* 
10 
(17.86%) 
 
48  
(17.33%) 
 
100  
(13.07%) 
 
135  
(9.73%) 
 
293  
(11.79%) 
4 < 1, 2, 3 
Meth            
  Past 12 months 119.68** 
9 
 (15.00%) 
 
123 
 (42.41%) 
 
337  
(41.71%) 
 
337  
(22.50%) 
 
806  
(30.35%) 1, 4 < 2, 3 
  Past 30 days 117.01** 
8  
(13.33%) 
 
107  
(36.90%) 
 
301  
(37.25%) 
 
280  
(18.69%) 
 
696 
 (26.20%) 1, 4 < 2, 3 
  Positive UA 45.44** 
13 
(23.21%) 
 
99  
(35.74%) 
 
308  
(40.26%) 
 
371 
(26.75%) 
 
791  
(31.83%) 
1, 4 < 3; 
4 < 2 
 
Notes: Percentage calculated within self-reported (medical) marijuana use. 
Pearson’s Chi-squared test.  
Significant contrast presents among AuMM users (1), NonAuMM users (2), NonAuM users (3), and Non users (4). 
*p<. 05; **p<.001 (two-tailed test). 
 
significantly more likely to test positive than Non-users. Last, self-report and urinalysis 
for methamphetamine use was significantly different among four groups. NonAuMM 
users and NonAuM users were significantly more likely to self-report using 
methamphetamine in the past 12 months and 30 days than AuMM users and Non-users. 
In terms of urinalysis results, NonAuM users were significantly more likely to test 
                                                                            
    
46 
 
positive for meth than AuMM users and Non-users, and NonAuMM users were more 
likely to get positive results on meth use than Non-users. These bivariate relationship 
tests demonstrate that arrestees who use marijuana of any type are significantly more 
likely to use cocaine and opiate, and AuMM users and Non-users were significantly less 
likely to use meth. 
Multivariate relationships. Table 9 indicates the multivariate relationship between 
substance use and types of self-reported marijuana use in the past 30 days, controlling for 
individual and situational characteristics by using logistic regression. The coefficient (b), 
standard errors (SE), and the odds ratio (OR) are presented for each of the independent 
variables. All models had significant χ2 values at the p < .0001 level for the model-fit 
diagnosis and the predictive powers of all the models were higher than .7, which is 
considered acceptable discrimination (Hosmer & Lemeshow, 2000).  
First, AuMM users did not significantly differ in alcohol drinking compared to 
NonAuMM users, NonAuM users, and Non-users
11
. Mental health risks, race/ethnicity, 
and education attainment were associated with drinking alcohol and respondent who did 
not report income were significantly less likely to drink alcohol. Second, AuMM users 
did not significantly differ in their use of cocaine compared to NonAuMM users, 
NonAuM users, and Non-users
12
.  Mental health risk and number of prior arrests were  
                                                          
11
 Additional logistic regressions were run with different reference groups. The results showed 
that NonAuMM users and NonAuM users were significantly more likely to drink alcohol than 
Non-users (b = .73, p <.001; b = .68, p <.001, respectively). The odds of drinking alcohol will 
increase 106% for being a NonAuMM user and by 97% for being a NonAuM user.  
 
12
 Additional logistic regressions were run with different reference groups. The result showed that 
NonAuMM users were significantly more likely to use cocaine than NonAuM users (b = .50, p 
<.05). The odds of using cocaine will increase by 65% for being a NonAuMM. In addition, 
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Table 9. The Effect of Types of Self-reported Marijuana Use on Substance Use in the Last 12 
Months 
Variables 
Alcohola  Cocainea  Opiatea  Metha 
b (SE) OR  b (SE) OR  b (SE) OR  b (SE) OR 
NonAuMM usersb .39 (.33) 1.48  .54 (.51)   1.71  -.29 (.50)   .75  1.40 (.48)   4.06* 
NonAuM usersb .34 (.31) 1.41  .04 (.50) 1.04  -.19 (.48)   .83  1.64 (.47)   5.20* 
Non-usersb -.34 (.30) .72  -0.79 (.51) .45  -.20 (.48)   .82  .82 (.47) 2.27 
Gang membership .09 (.23) 1.10  .42 (.29)   1.53  -.02 (.34)   .98  .19 (.25) 1.22 
Mental health risk .48 (.09)       1.61**  .84 (.20) 2.31**  3.12 (.42) 22.74**  1.69 (.13) 5.41** 
Prior arrests -.03 (.02) .97  .07 (.03)   1.07*  .10 (.03) 1.10**  .11 (.02) 1.11** 
Age .00 (.00) 1.00  -.02 (.01)  .98*  -.04 (.01) .96**  .03 (.01) 1.03** 
Male .16 (.10) 1.17  .20 (.21)   1.22  -.07 (.18)     .93  -.59 (.12) .55** 
African American .43 (.13) 1.54*  .12 (.26)   1.13  -1.43 (.33)      .24**  -1.25 (.18) .29** 
Hispanic .33 (.11) 1.39*  .58 (.20) 1.79*  -.95 (.22) .38**  -.66 (.13) .52** 
Other 1.08 (.19) 2.94**  -.08 (.36)     .92  -1.67 (.43) .19**  -1.50 (.24) .22** 
High school graduate .30 (.10) 1.35*  .00 (.18)   1.00  .46 (.19)   1.58*  -.45 (.12) .64** 
Illegal income  -.21 (.15) .81  .40 (.21)  .49  1.01 (.18) 2.76**  .97 (.15) 2.64** 
No income -.33 (.14) .72*  .03 (.31) 1.03  .37 (.27)  1.44  .10 (.18)   1.11 
Medical insurance -.10 (.09) .91  .13 (.17) 1.14  -.34 (.17)         .71*  -.42 (.11) .66** 
Intercept -.02 (.36)   -2.90 (.64)   -3.62 (.71)   -3.37 (.53)  
 
Model χ2 
McFadden’s R2 
 
147.94** 
.05 
2,514 
  
130.19** 
.10  
 
357.08** 
.24 
  
655.45** 
.23 
N  2,520  2,519  2,520 
Notes: Entries are unstandardized coefficients (b), standard errors in parentheses, and odds ratios. 
a Logistic regression equation. 
b AuMM users are the reference group. 
*p<.05; **p<.001 (two-tailed test). 
 
positively related to cocaine use, and younger arrestees were significantly more likely to 
use cocaine. Third, there was no observed difference in opiate use between AuMM users 
and the other three groups. Mental health risk and number of prior arrests were positively 
related to opiate use. Younger high school graduate arrestees were significantly more 
                                                                                                                                                                             
NonAuMM users and NonAuM users were significantly more likely to use cocaine than Non-
users (b = 1.33, p <.001; b = .83, p <.001, respectively). The odds of using cocaine will increase 
by 276% for being a NonAuMM user and by 128% for being a NonAuM user.  
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likely to use opiate. Having illegal income sources was positively related to opiate use, 
and arrestees with medical insurance were less likely to use opiates. Last, with regard to 
methamphetamine use, NonAuMM users and NonAuM users were significantly more 
likely to use meth compared with AuMM users (b = 1.40, p <.05; b = 1.64, p <.05, 
respectively)
13
. The odds of using meth increased by 306% for NonAuMM users and by 
420% for NonAuM users when controlling for other characteristics. Other control 
variables were significantly related to meth use among arrestees; mental health risk, 
number of prior arrests, age, and having an illegal income source were positively related 
to meth use. Males were less likely to use meth than females, and arrestees who had 
medical insurance were less likely to use meth.   
To illustrate the unit effects of independent variables on the probability of 
substance use, Figure 2 shows the estimated probability of substance use at any time 
during the past 30 days by different types of self-reported marijuana use among arrestees. 
The results demonstrated that being NonAuMM user (18.04%), NonAuM user (16.84%), 
and AuMM user (8.43%) were will increase the probability of drinking alcohol at any 
time during the previous 30 days when other confounding factors are controlled. In 
addition, being a NonAuMM user will increase the probability of using cocaine at any 
time during the previous 30 days (3.65%). Types of marijuana used had little impact on 
opiate use. However, being a NonAuM user increased the probability of using meth at 
                                                          
13
 Additional logistic regressions were run with Non-users as the reference group. The result 
indicated that NonAuMM users and NonAuM users were significantly more likely to use meth 
than Non-users (b = .58, p <.05; b = .82, p <.001, respectively). The odds of using cocaine will 
increase by 78% for being a NonAuMM user and by 127% for being a NonAuM user.  
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any time during the past 30 days (25.50%), followed by being a NonAuMM user 
(20.26%) and a Non-user (9.69%). 
 
 
Figure 2. Probability of Substance Use by Different Types of Self-reported 
Marijuana Use among Arrestees in Maricopa County, AZ. 
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CHAPTER 5 
DISCUSSION 
The current study contributes to medical marijuana research in two important 
ways. First, it explored the general characteristics and marijuana acquisition patterns of 
medical marijuana users by comparing those characteristics among authorized medical 
marijuana users (AuMM users), non-authorized medical marijuana users (NonAuMM 
users), non-authorized marijuana user (NonAuM users), and non-marijuana users (Non-
users). Consistent with prior studies, medical marijuana users in the sample of this study 
were more likely to be a male and younger (Reinarman et al., 2011). There was no 
difference between AuMM and NonAuMM users with respect to gender, race/ethnicity, 
age, income source, gang membership, number of prior arrests, and having medical 
insurance. However, AuMM users were more likely to be high school graduates, but less 
likely to have mental health risk than NonAuMM users.  
In terms of marijuana acquisition patterns, AuMM users and NonAuMM users 
were likely to acquire more marijuana and spend more money on obtaining marijuana 
compared with NonAuM users. In terms of marijuana acquisition source, most of the 
AuMM users obtained marijuana from legal dispensaries or grew their own. Surprisingly, 
NonAuMM users and NonAuM users also obtained some portion of marijuana from legal 
dispensaries, although they did not have a legal medical marijuana ID card. It should not 
be occurring and suggest potential problems, such as illegal medical marijuana trafficking.  
Second, because obtaining information about criminal involvement or illegal drug 
use among medical marijuana users is often too sensitive to obtain, little prior research 
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has explored this relationship. By using an arrestee sample, this study explored the 
relationship between medical marijuana use and criminal involvement, including illegal 
drug use at the individual level. The key findings indicated that AuMM users had a 
significantly higher probability for DUI than Non-users and had a higher probability for 
drug selling/making than NonAuM user and Non-users. It may reflect their legal growing 
of medical marijuana. NonAuMM users were significantly more likely to be involved in 
property crime, violent crime, DUI, and drug selling/making than Non-users. In terms of 
other drug use, NonAuMM and NonAuM users had a higher probability for meth use 
compared with AuMM users, and NonAuMM users were more likely to use cocaine than 
the other types of users.  
While the current study is a step toward a better understanding of the relationship 
between criminal involvement and medical marijuana users, some limitations should be 
addressed for future research. First, since the data was limited to a sample of arrestees in 
Maricopa County, AZ, the findings presented in this study should not be generalized to 
other samples or populations from different states. For example, since this study uses a 
sample of arrestees, authorized medical marijuana users’ criminal involvement may be 
overestimated. Second, information from survey questions was limited. This study 
categorized arrestees by type of self-reported marijuana use. It captured whether they had 
a medical marijuana ID card, used medical marijuana in the past 30 days, and used 
marijuana in the past 30 days. However, there was no question asking whether people use 
marijuana for medical purposes; it would be meaningful to compare people regarding the 
purpose of their marijuana use. For example, if people who don’t have enough money to 
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apply for a medical marijuana ID card want to use marijuana for only treating their 
physical illness, it might result in different use patterns than people who use it for 
recreational purposes. In addition, there was no information about which drug was used 
when they drove under the influence; this study cannot conclude that AuMM users who 
committed DUI of marijuana are not different from NonAuMM users who committed 
DUI of other illegal drugs. In terms of drug selling/making, there was not a distinguishing 
question between whether the respondent had been sold drugs or whether they had made 
drugs; it is possible that medical marijuana ID cardholders may be over-represented in 
illegal drug selling/making behaviors because they can legally cultivate marijuana. 
Marijuana cultivation cannot be interpreted as criminal involvement among those with a 
medical marijuana ID card. More specific questions would provide additional insights to 
understand the relationship between medical marijuana and criminal involvement.   
 Finally, the study relied on self-reported measures because official data was not 
available for medical marijuana use and criminal involvements/drug use; using self-
reported data could contain several potential biases. For example, the arrestees with 
medical marijuana ID cards may under-report criminal involvement or illegal drug use 
for fear of any impact on maintaining their medical marijuana ID card. In addition, if 
there are individuals who are planning to apply for a medical marijuana ID card, they 
might feel that self-reporting crimes and illegal drug use could reduce their chances of 
obtaining a medical marijuana ID card.  
This research design, however, included efforts to reduce the possible biases such 
as assuring participants’ anonymity (e.g., by not collecting arrestees’ names or 
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identification numbers). In addition, there is strong evidence that suggests that the self-
report methodology is a valid and reliable method of gathering data on delinquency and 
drug use in general (Junger-Tas & Marshall, 1999; Thornberry & Krohn, 2000).  
According to Farrington, Jolliffee, Hawkins, Catalano, and Kosterman (2003), it is 
significantly better than official data from chronic offenders. Katz, Webb, Gartin, and 
Marshall (1997) examined the validity of self-reported drug use among arrestees using 
the Drug Use Forecasting (DUF) sample and derived supportive conclusions for validity 
of self-report methodology.  In addition, Webb, Katz, and Decker (2006) used both self-
reported and an objective measure of drug use (e.g., urinalysis) from the ADAM project 
to examine the relationship between drug use and gang membership. The findings also 
suggested that self-reported data obtained from arrestees is a robust method for 
understanding their recent behaviors.  
Even with these limitations, this study has important implications for medical 
marijuana policy and future research. First, whereas there was no significant difference in 
property crime and violent crime between AuMM users and other three groups, 
NonAuMM users were more likely to be involved in all crime types (e.g., property crime, 
violent crime, DUI, and illegal drug dealing/making) than Non-users. They were also 
more likely to use cocaine and more likely to be involved in risky behavior (e.g., having 
illegal income source, being in a gang, etc.). However, it is unknown how they obtained 
medical marijuana, what their purpose was for obtaining medical marijuana, why they 
used medical marijuana and not street marijuana, and so on. It would be important to 
investigate this population to understand the medical marijuana-related crimes.  
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Second, a number of states have adopted dissimilar medical marijuana laws. It 
would be beneficial to establish policies and procedures that adhere to consistent laws 
across the states in order to adequately respond to certain situations and provide regular 
education about different regulations by states to medical marijuana users. Especially, the 
issue with DUI of marijuana for medical marijuana ID card holders, which is still debated 
heavily, needs to be considered nationally. For example, ten states, including Arizona, 
Delaware, Georgia, Illinois, Indiana, Iowa, Michigan, Rhode Island, Utah, and Wisconsin, 
have a zero-tolerance policy on DUI of marijuana even when there is no evidence of 
impairment for driving. However, under the Nevada, Ohio, Pennsylvania, and 
Washington law, anyone driving with certain level for THC and/or its metabolites is 
considered impaired driving 
14
(Armentano, 2013). In 2013, the Michigan Supreme Court 
ruled that medical marijuana users aren’t automatically guilty of DUI, even if they are 
caught driving after using the drug. That court found that medical marijuana users should 
have some protections and that police must show that a driver was actually impaired 
because of marijuana use (Skoloff, April 24, 2014) because  some drivers with severe 
pains would be more dangerous than with low level of THC in their blood. However, 
there is no consensus as to what specific blood THC thresholds should be for driving 
impairment (Armentano, 2013).   
                                                          
14
 The limits in these states are as follows: Nevada: 2ng/ml THC in blood or 15ng/ml of carboxy 
THC in blood or urine; Ohio: 2ng/ml THC in blood or 35ng/ml of carboxy THC in blood or urine; 
Pensylvania: 1ng/ml THC in blood or 1ng/ml of carboxy THC in blood or urine; Washington: 
5ng/ml THC in blood. 
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Last, medical marijuana can play a role in reducing costs in the health care system. 
Medical marijuana, as a prescribed medication, is inexpensive to produce. However, not 
one major health insurer covers medical marijuana because the FDA has not approved it. 
According to Montopoli (2009), “Lack of FDA approval means no coverage either by 
private insurer or through any public plan to be drafted by Congress.” Many 
pharmaceutical companies also greatly oppose its coverage under health insurance 
because a cheaper alternative, which is medical marijuana, will dramatically reduce 
health care costs for prescription drug coverage (Jackson, 2013). Since a certain portion 
of people in the sample of this study were NonAuMM users who were using medical 
marijuana without a legitimate ID card, and they were more likely to be involved in 
property or violent crime than non-marijuana users, it is possible that there are some 
people with chronic pain, but who don’t have enough money to get a medical marijuana 
ID card or medical marijuana. They could steal some money from others and obtain 
marijuana through illegal drug markets. Under the medical model, these people will be 
less likely to be involved in illegal drug trafficking.    
Studies to date have not yet examined medical marijuana users’ criminal 
involvement specifically; however, the present study suggests that authorized medical 
marijuana users may have not much impact on escalating criminal involvements as other 
drug users. Moreover, this study indicates that noon-authorized medical marijuana users 
may have potential problems regarding criminal involvement. Future research that 
addresses the limitations discussed in this study would have the potential to add greatly to 
the literature on medical marijuana.  
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